Core Insights - The Oncology Institute, Inc. (TOI) has been selected to present an abstract at the ASCO Annual Meeting, highlighting the cost savings and reduced hospitalizations associated with its High-Value Cancer Care (HVCC) model [1][2] - The HVCC model has demonstrated over 50% reductions in Emergency Department utilization and hospitalizations, along with cost savings exceeding $12,000 per patient enrolled [2][5] Company Overview - Founded in 2007, TOI specializes in value-based cancer care, serving over 1.8 million patients with a team of over 120 clinicians and more than 700 staff across 70 clinic locations [4] - TOI's approach includes evidence-based cancer care, clinical trials, and transfusions, aiming to improve oncology care in community settings [4] Clinical Outcomes - Recent data indicates a 53% reduction in Emergency Department use, a 68% decrease in hospitalizations, and a 75% lower odds of death in acute care facilities for patients enrolled in the HVCC model [5] - The total cost of care is lowered by $12,000 per enrolled patient, further validating the effectiveness of TOI's care model [5]